Valuation : CTT Pharmaceutical Holdings, Inc.

Market Cap 2.85M 2.45M 2.3M 2.1M 3.94M 269M 3.95M 27.23M 10.56M 138M 10.69M 10.45M 444M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 2.85M 2.45M 2.31M 2.11M 3.94M 269M 3.95M 27.26M 10.58M 138M 10.7M 10.47M 445M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
1 day-3.06%
1 week-3.00%
Current month-0.55%
1 month-25.38%
3 months-37.74%
6 months-34.46%
Current year-19.31%
1 week 0.04
Extreme 0.0449
0.06
1 month 0.04
Extreme 0.0401
0.07
Current year 0.04
Extreme 0.0401
0.1
1 year 0.04
Extreme 0.035
0.1
3 years 0
Extreme 0.0031
0.15
5 years 0
Extreme 0.003
0.15
10 years 0
Extreme 0.003
2.17
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 A BuyCompany 3,000 0.0051%
8/31/26 A BuyCompany 3,500 0.0060%
8/24/26 A BuyCompany 2,100 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-3.06%-3.00%+1.40%+457.47% 2.85M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -1.13%+0.17%+65.98%+148.28% 27.5B
Weighted average by Cap. -1.03%+0.11%+89.42%+127.93%

Financials

2024 2025
Net sales - -
Net income -250K -215K -203K -185K -346K -23.63M -347K -2.39M -929K -12.12M -940K -919K -39.05M -156K -134K -126K -115K -216K -14.72M -216K -1.49M -579K -7.55M -585K -573K -24.33M
Net Debt 16.82K 14.47K 13.62K 12.44K 23.27K 1.59M 23.33K 161K 62.44K 815K 63.16K 61.78K 2.62M 3.46K 2.97K 2.8K 2.56K 4.78K 326K 4.79K 33.05K 12.83K 167K 12.97K 12.69K 539K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-
Date Price Change Volume
04/09/26 $0.0485 -3.06% 8,960
03/09/26 $0.0500 +2.27% 27,030
02/09/26 $0.0489 -2.22% 32,575
01/09/26 $0.0500 +2.52% 43,000
31/08/26 $0.0488 -2.46% 5,500
  1. Stock Market
  2. Stocks
  3. CTTH Stock